Comment on: Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica:: comparison of disease characteristics and treatment requirement. Reply

Kornelis S M van der Geest; Maria Sandovici; A Rutgers; Elisabeth Brouwer

doi:10.1093/rheumatology/keae261

Comment on: Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement. Reply

Kornelis S M van der Geest^*, Maria Sandovici, A Rutgers, Elisabeth Brouwer

^*Corresponding author voor dit werk

Onderzoeksoutput › Academic › peer review

13 Downloads (Pure)

Originele taal-2	English
Pagina's (van-tot)	902-903
Aantal pagina's	2
Tijdschrift	Rheumatology (Oxford, England)
Volume	64
Nummer van het tijdschrift	2
DOI's	https://doi.org/10.1093/rheumatology/keae261
Status	Published - feb.-2025

Toegang tot document

10.1093/rheumatology/keae261Licentie: CC BY-NC

Comment on Immune checkpoint inhibitor-mediated polymyalgiaFinal publisher's version, 352 KBLicentie: CC BY-NC

Handle.net

Permanente koppeling

1 Erratum

Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement
Vermeulen, O. C. B., Brouwer, E., Slart, R. H. J. A., Sandovici, M., Rutgers, A., Hilterman, T. J., Hiddinga, B., Oosting, S. F., Jalving, M., de Heij, A. H., Knapen, D. G., Hospers, G. A. P. & van der Geest, K. S. M., feb.-2025, In: Rheumatology (Oxford, England). 64, 2, blz. 771-779 9 blz.
Onderzoeksoutput

Open Access
Bestand
4 Citaten (Scopus)

23 Downloads (Pure)

Citeer dit

@article{2d581096a11a4f6e8c96322e08b86ec1,

title = "Comment on: Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica:: comparison of disease characteristics and treatment requirement. Reply",

author = "{van der Geest}, {Kornelis S M} and Maria Sandovici and A Rutgers and Elisabeth Brouwer",

year = "2025",

month = feb,

doi = "10.1093/rheumatology/keae261",

language = "English",

volume = "64",

pages = "902--903",

journal = "Rheumatology (Oxford, England)",

issn = "1462-0324",

publisher = "Oxford University Press",

number = "2",

}

TY - JOUR

T1 - Comment on: Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica:

T2 - comparison of disease characteristics and treatment requirement. Reply

AU - van der Geest, Kornelis S M

AU - Sandovici, Maria

AU - Rutgers, A

AU - Brouwer, Elisabeth

PY - 2025/2

Y1 - 2025/2

U2 - 10.1093/rheumatology/keae261

DO - 10.1093/rheumatology/keae261

M3 - Comment/Letter to the editor

C2 - 38741187

SN - 1462-0324

VL - 64

SP - 902

EP - 903

JO - Rheumatology (Oxford, England)

JF - Rheumatology (Oxford, England)

IS - 2

ER -

Comment on: Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement. Reply

Toegang tot document

Handle.net

Onderzoekersoutput

Immune checkpoint inhibitor-mediated polymyalgia rheumatica versus primary polymyalgia rheumatica: comparison of disease characteristics and treatment requirement

Citeer dit